Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Company News
Events
Directory
Search
Close search
Home
Company
Fareva
Fareva
Activities:
Manufacturing
Ingredients
X
LinkedIn
Trending Articles
LUNA 3: Rilzabrutinib Phase III immune thrombocytopenia trial meets primary endpoint
Rilzabrutinib met both the primary endpoint of durable platelet response and various secondary endpoints in patients who were refractory to prior therapy
Fasenra for EGPA: addressing unmet needs
Benralizumab could offer patients with EGPA more treatment options, while reducing dependency on oral corticosteroids
Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222
Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
Chemistry, manufacturing and control (CMC) as key drivers for drug discovery success
Embracing collaborative strategies not only accelerates drug development programmes but also fosters science-based milestone decisions, mitigates risks and prepares for...
Bristol Myers Squibb and Cellares partner to expand CAR-T manufacturing capabilities
Cellares will optimise and automate select Bristol Myers Squibb CAR-T cell therapies onto its high-throughput manufacturing program, the Cell Shuttle
Upcoming event
Cleanroom Conference UK
22–23 May 2024 | Exhibition | Birmingham, UK
See all
Related Content
Drug Delivery
Fareva completes high potency drug investment
The program started in 2016 at the site of Fareva La Vallée
Manufacturing
Abionyx signs partnership with GTP Biologic and V-Nano
GTP Biologics is part of the Fareva Group, while V-Nano is part of the VBI Therapeutics Group
Regulatory
To comply with EU FMD Fareva selects TraceLink
The API CDMO has selected the track and trace network provider, so that it can successfully connect with its pharmaceutical customers
Containment
Fareva acquires former Merck API manufacturing facility
Acquisition adds another world-class facility to the company's pool of 35 facilities in 11 countries
Subscribe now